Gm1 gangliosidosis and galactosialidosis : pathogenesis and therapy

Doctoral thesis English OPEN
Martin, M. (2003)
  • Publisher: Erasmus University Rotterdam

textabstractGM1 gangliosidosis and galactosialidosis belong to the large group of metabolic disorders collectively known as Iysosomal storage diseaSE!S (lSDs). lSDs are caused by a single or combined deficiency of specific hydr,olytic enzymes resulting in progressive accumulation of undigested substrates in Iysosomes of many cells, and ultimately in cellular and organ dysfunction. In general, the patients exhibit multi-systemic symptoms mostly involving severe neurological manifestations. Tlle severity and onset of the symptoms range frlom neonatal to adulthood and ofte!n correlate with the level of residual enzyme activity. Phenotypic variations are particularly Iwidenlt in the broad range of neurological symptoms that include mental retardation, motor dysfunction, sensory deficits, and seizures. Although some clinical manifestations are common in different lSDs it is becoming increasingly cleCllr that at tlhe cellular level each individual disease displays a distinct and characteristic pattern of morphological changes and extent of cellular dysfunction. The pathogenesis of each disease is, therefore, deî1ermined by the enzyme function in different cel! types and in turn by the type and amount of accumulated products. The main objective elf the present study was to gain a better understanding of the molecular bases of GMh-ganglliosidosis and galactosialidosis aml to use genetic approaches as curative therapy for murine galactosialidosos. The detailed characterization of the tWCI mouse models of these two diseases heliS provided new insights onto the molecular and cellular mechanisms that unc:lerlie neuronal degeneration in GM1 gangliosiclosis and has given the bases for implementing efficient strategies for the (;ure of galactosialidosis.
  • References (28)
    28 references, page 1 of 3

    Asahara, T., Kalka, C. and Isner, J.M. (2000) Stem cell therapy and gene transfer for regeneration. Gene Ther, 7, 451-457.

    Brooks, A.I., Stein, C.~,., Hughes, S.M., Heth, J., McCray, P.M., Jr., Sauter, S.L., Johnston, J.C., CorySiechta, OA, Federoff, H.J. and Oavidson, B.L. (2002) Functional correction of established central nervous system deficits in an animaI model of Iysosomal storage disease with feline immunodeficiency virus-based vectors. Prae Natl Aead Sei U SA, 99, 6216-6221.

    Elsea, S.H. and Lucas, R.E. (2002) The mousetrap: wh at we can learn when the mouse modl31 does not mimic the human diseasl3. ILAR J, 43, 66-79.

    Gotoh, T., Oyadomari, S., Mori, K. and Mori, M. (2002) Nitric oxide-induced apoptosis in RAW 264.7 macrophages is mediated by endoplasmie reticulum stress pathway involving ATF6 and CHOP. J Biol Ghem, 277,12343-12350.

    Hickey, W.F. and Kimura, H. (1988) Perivascular microglial eells of the CNS are bone marrow-derived and present antigen in vivo. Science, 239, 290-292.

    Imaizumi, K., Miyoshi, ~(., Katayama, T., Yoneda, T., Taniguchi, M., Kudo, T. and Tohyama, M. (2001) The unfolded protein response and Alzheimer's disease. Biochim Biophys Acta, 1536, 85-96.

    Jeyakumar, M., I\lorl'lus, F., Tifft, G.J., Cortina-Borja, M., Buttel's, T.D., Proia, R.L., Perry, V.H., Owek, RA and Platt, F.M. (2001) Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation. Blood, 97, :327-329.

    Kaufman, R.J. (1999) Stress signaling from the lumen of the endoplasmie reticulum: coordination of gene transcriptional anel translational controls. Genes Dev, 13, 1211-1233.

    Kolter, T. and Sandhoff, K. (1998) Glycosphingolipid degradation and animal models of GM2-gangliosidoses.

    J Inherit Metab Dis, 2-1, !548-563.

  • Similar Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark